Zydus Lifesciences Ltd (532321) Stock Price & News

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020. Wikipedia

About Zydus Lifesciences Ltd

CEO-

Employees30 k

Founded1952

Headquarters-

SectorPharmaceutical industry

Websitezyduslife.com

All values in INR	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	61,23 mjd	68,64 mjd	75,87 mjd	80,17 mjd
Cost of goods sold	16,90 mjd	18,36 mjd	22,07 mjd	22,40 mjd
Cost of revenue	16,90 mjd	18,36 mjd	22,07 mjd	22,40 mjd
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	10,34 mjd	11,40 mjd	32,92 mjd	13,68 mjd
Operating expense	31,33 mjd	37,36 mjd	39,40 mjd	44,59 mjd
Total operating expenses	48,23 mjd	55,72 mjd	61,48 mjd	66,99 mjd
Operating income	13,00 mjd	12,92 mjd	14,39 mjd	13,18 mjd
Other non operating income	1,09 mjd	1,11 mjd	-3,70 mjd	1,06 mjd
EBT including unusual items	16,93 mjd	14,11 mjd	16,59 mjd	13,44 mjd
EBT excluding unusual items	17,27 mjd	14,96 mjd	20,88 mjd	13,63 mjd
Income tax expense	4,54 mjd	3,88 mjd	3,18 mjd	3,54 mjd
Effective tax rate	26,82%	27,52%	19,19%	26,35%
Other operating expenses	17,97 mjd	22,36 mjd	1,28 mjd	25,36 mjd
Net income	12,59 mjd	10,42 mjd	12,72 mjd	9,40 mjd
Net profit margin	20,55%	15,18%	16,77%	11,72%
Earnings per share	12,76	10,96	15,84	9,48
Interest and investment income	-	-	4,24 mjd	-
Interest expense	-1,01 mjd	-1,30 mjd	-491,00 m	-1,56 mjd
Net interest expenses	-1,01 mjd	-1,30 mjd	3,75 mjd	-1,56 mjd
Depreciation and amortization charges	3,02 mjd	3,60 mjd	5,08 mjd	5,55 mjd
EBITDA	15,70 mjd	15,10 mjd	17,74 mjd	16,53 mjd
Gain or loss from assets sale	-	-	-	-

Ask anything